临床试验

Enterprise 2 Vascular Reconstruction Device

NCT：NCT05254067 · COMPLETED

NCT编号NCT05254067

状态COMPLETED

开始日期2017-02-28

完成时间2026-01-05

SponsorMethodist Health System (OTHER)

First posted2022-02-24

Last updated2026-05-18

简要摘要

The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。